金河生物: 关于控股股东减持计划完成暨减持结果的公告

Core Viewpoint - The controlling shareholder of Jinhe Biological Technology Co., Ltd., Inner Mongolia Jinhe Holdings Co., Ltd., plans to reduce its shareholding by a total of 22,563,389 shares, accounting for 3% of the company's total share capital, through various trading methods from June 10, 2025, to September 9, 2025 [1]. Shareholder Reduction Details - The reduction was completed between August 11, 2025, and September 1, 2025, with a total of 22,563,100 shares sold, also representing 3% of the company's total share capital after excluding repurchased shares [2]. - The reduction was executed through two methods: 15,042,100 shares via block trading at an average price of 6.81 yuan per share, and 7,521,000 shares via centralized bidding at an average price of 7.26 yuan per share [3]. - Prior to the reduction, the controlling shareholder and its concerted actors held a total of 278,744,052 shares, which was 34.0615% of the total share capital after excluding repurchased shares [4]. Shareholding Structure Post-Reduction - After the reduction, the controlling shareholder's stake decreased to 241,758,670 shares, representing 32.1439% of the total share capital [4]. - The total shareholding of the controlling shareholder and its concerted actors post-reduction is 256,180,952 shares, which is 33.1998% of the total share capital [4]. - The shareholding structure includes 271,305,120 shares with no restrictions and 7,438,932 shares with restrictions [4].